Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
velagluceras alfa 400 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
velagluceras alfa 200 enheter, frystorkat pulver till injektionsvätska |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
tesamorelin (som tesamorelinacetat) 1 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
belimumab 400 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
belimumab 120 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
kanakinumab 150 mg, pulver till injektionsvätska, lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
abobotulinumtoxin A 500 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
humant immunglobulin G 6 gram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
mitomycin 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
oktokog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
oktokog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
teduglutid 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
onabotulinumtoxin A 200 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
onabotulinumtoxin A 100 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
kanakinumab 150 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
lurbinektedin 4 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
azacitidin 100 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
remimazolam (som remimazolambesilat) 20 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
Clostridium histolyticum-kollagenas 900 mikrog/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|
trilaciklib (som trilaciklibdihydroklorid) 300 mg/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Lyophilized powder for conventional release solution for injection (dose form) |
Inferred relationship |
Some |
|